CanSinoBIO’s vaccine is a recombinant viral vector vaccine, a class of vaccines that use a modified version of a different virus to deliver instructions to cells that trigger an immune response.

The Ad5-EBOV vaccine developed in China relies on the recombinant replication-defective human adenovirus type-5 vector to induce immune responses and provide protection against the Ebola virus.

Two important contributors of early protection are speed of replication and onset of immunity, according to Alberto Giner, ...

This new system will aid researchers in developing vaccines ... virus still provides the necessary proteins and machinery required for the synthetic DNA to replicate and assemble into new virus ...

Cell- or recombinant-based influenza vaccines will include an A/Wisconsin/67/2022 (H1N1)pdm09-like virus; an A/District of Columbia/27/2023 (H3N2)-like virus; and a B/Austria/1359417/2021 (B ...

The recombinant zoster vaccine (RZV) Shingrix demonstrated effectiveness in preventing herpes zoster (HZ) and postherpetic neuralgia among adults aged 50 years or older with rheumatoid arthritis (RA).

The combination of synchronous experimental process development and digital twin core model development is among the first of its kind.

A vaccine against meningococcal disease or any other disease works by generating an immune response in the body against some kind of pathogen—a virus, bacterium, or some other agent that causes ...

Humans, livestock and companion animals benefit from virus-based vaccines and gene therapies ... "Additionally, viral vector applications allow for temporary improvements, offering an attractive ...

Find all the commercial and brand names of generic drug called Hepatitis B (recombinant) vaccine. This is an invaluable reference resource for healthcare professionals, patients, caregivers and ...